Vol 2009, No 9 (2009)

Table of Contents

Research & Development

Amylin Heads to India for Diabetes Developments Abstract
Taskin Ahmed

Licensing

Bayer Signs Global Agreement for Alpharadin with Algeta Abstract
Taskin Ahmed

Mergers & Acquisitions

P&G Sells Pharma Division to Focus on Consumer Business Abstract
Taskin Ahmed
Ligand Acquires Neurogen and Access to Merck Partnership Abstract
Taskin Ahmed
Another Japanese Co Gets a Foothold in US Market Abstract
Taskin Ahmed
LEO Targets Peplin for Skin Cancer Drug Abstract
Taskin Ahmed
Alcon Enters Biologicals Arena Abstract
Taskin Ahmed
Taisho Buys OTC Assets from Bristol-Myers Abstract
Taskin Ahmed
Qiagen Acquires Molecular Diagnostics Company DxS Abstract
Taskin Ahmed

Editorial

Personalised Medicine – a Step Closer Abstract
Taskin Ahmed

Technology Access

Shire Targets More Rare Diseases with Santaris’ LNA Platform Abstract
Taskin Ahmed
PTC’s Gene Expression Technology Wins Over Roche and Celgene Abstract
Taskin Ahmed

Opinion & Analysis

Deal Making Trends in Oncology Abstract
Josef Walker


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.